Malignant Extraskeletal Cartilaginous and Osseous Neoplasm

Malignant Extraskeletal Cartilaginous and Osseous Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02180867	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery	completed	Phase 2 / Phase 3	140	National Cancer Institute (NCI)NIH	3	Jun 17, 2026	clinicaltrials
NCT00346164	Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	completed	Phase 3	588	Children's Oncology GroupNETWORK	5	Apr 28, 2022	clinicaltrials
NCT01532687	Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma	completed	Phase 2	54	OHSU Knight Cancer InstituteOTHER	1	Sep 27, 2021	clinicaltrials
NCT01154452

Data updated 23 days agoSource updated Jun 17, 2026source: clinicaltrials